274 related articles for article (PubMed ID: 9790519)
1. Antioxidant content in low density lipoprotein and lipoprotein oxidation in vivo and in vitro.
Tertov VV; Sobenin IA; Kaplun VV; Orekhov AN
Free Radic Res; 1998 Aug; 29(2):165-73. PubMed ID: 9790519
[TBL] [Abstract][Full Text] [Related]
2. Metabolism of native and naturally occurring multiple modified low density lipoprotein in smooth muscle cells of human aortic intima.
Tertov VV; Orekhov AN
Exp Mol Pathol; 1997; 64(3):127-45. PubMed ID: 9439479
[TBL] [Abstract][Full Text] [Related]
3. How different constituents of human plasma and low density lipoprotein determine plasma oxidizability by copper.
Spranger T; Finckh B; Fingerhut R; Kohlschütter A; Beisiegel U; Kontush A
Chem Phys Lipids; 1998 Jan; 91(1):39-52. PubMed ID: 9488998
[TBL] [Abstract][Full Text] [Related]
4. How different constituents of low density lipoprotein determine its oxidizability by copper: a correlational approach.
Kontush A; Hübner C; Finckh B; Kohlschütter A; Beisiegel U
Free Radic Res; 1996 Feb; 24(2):135-47. PubMed ID: 8845914
[TBL] [Abstract][Full Text] [Related]
5. Ex vivo low-density lipoprotein oxidizability and in vivo lipid peroxidation in patients on CAPD.
Roob JM; Rabold T; Hayn M; Khoschsorur G; Resch U; Holzer H; Winklhofer-Roob BM
Kidney Int Suppl; 2001 Feb; 78():S128-36. PubMed ID: 11168998
[TBL] [Abstract][Full Text] [Related]
6. Content of antioxidants, preformed lipid hydroperoxides, and cholesterol as predictors of the susceptibility of human LDL to metal ion-dependent and -independent oxidation.
Frei B; Gaziano JM
J Lipid Res; 1993 Dec; 34(12):2135-45. PubMed ID: 8301232
[TBL] [Abstract][Full Text] [Related]
7. Lack of correlation between degree of human plasma low density lipoprotein oxidation and its atherogenic potential.
Tertov VV; Kaplun VV; Orekhov AN
Biofactors; 1997; 6(2):139-43. PubMed ID: 9259995
[TBL] [Abstract][Full Text] [Related]
8. In vivo oxidized low density lipoprotein: degree of lipoprotein oxidation does not correlate with its atherogenic properties.
Tertov VV; Kaplun VV; Orekhov AN
Mol Cell Biochem; 1998 Jun; 183(1-2):141-6. PubMed ID: 9655188
[TBL] [Abstract][Full Text] [Related]
9. Low-density lipoprotein modification occurring in human plasma possible mechanism of in vivo lipoprotein desialylation as a primary step of atherogenic modification.
Tertov VV; Kaplun VV; Sobenin IA; Orekhov AN
Atherosclerosis; 1998 May; 138(1):183-95. PubMed ID: 9678784
[TBL] [Abstract][Full Text] [Related]
10. Apolipoprotein B-bound lipids as a marker for evaluation of low density lipoprotein oxidation in vivo.
Tertov VV; Kaplun VV; Dvoryantsev SN; Orekhov AN
Biochem Biophys Res Commun; 1995 Sep; 214(2):608-13. PubMed ID: 7677772
[TBL] [Abstract][Full Text] [Related]
11. Whole plasma oxidation assay as a measure of lipoprotein oxidizability.
Kontush A; Spranger T; Reich A; Djahansouzi S; Karten B; Braesen JH; Finckh B; Kohlschütter A; Beisiegel U
Biofactors; 1997; 6(2):99-109. PubMed ID: 9259991
[TBL] [Abstract][Full Text] [Related]
12. Multiple-modified desialylated low density lipoproteins that cause intracellular lipid accumulation. Isolation, fractionation and characterization.
Tertov VV; Sobenin IA; Gabbasov ZA; Popov EG; Jaakkola O; Solakivi T; Nikkari T; Smirnov VN; Orekhov AN
Lab Invest; 1992 Nov; 67(5):665-75. PubMed ID: 1434544
[TBL] [Abstract][Full Text] [Related]
13. Lipid composition of circulating multiple-modified low density lipoprotein.
Zakiev ER; Sukhorukov VN; Melnichenko AA; Sobenin IA; Ivanova EA; Orekhov AN
Lipids Health Dis; 2016 Aug; 15(1):134. PubMed ID: 27558696
[TBL] [Abstract][Full Text] [Related]
14. Low-density lipoprotein composition and oxidability in atherosclerotic cardiovascular disease.
Schreier LE; Sanguinetti S; Mosso H; Lopez GI; Siri L; Wikinski RL
Clin Biochem; 1996 Oct; 29(5):479-87. PubMed ID: 8884071
[TBL] [Abstract][Full Text] [Related]
15. Ubiquinol-10 protects human low density lipoprotein more efficiently against lipid peroxidation than does alpha-tocopherol.
Stocker R; Bowry VW; Frei B
Proc Natl Acad Sci U S A; 1991 Mar; 88(5):1646-50. PubMed ID: 2000375
[TBL] [Abstract][Full Text] [Related]
16. Distribution of lipid-soluble antioxidants in lipoproteins from healthy subjects. I. Correlation with plasma antioxidant levels and composition of lipoproteins.
Perugini C; Bagnati M; Cau C; Bordone R; Zoppis E; Paffoni P; Re R; Albano E; Bellomo G
Pharmacol Res; 2000 Jan; 41(1):55-65. PubMed ID: 10600270
[TBL] [Abstract][Full Text] [Related]
17. Antioxidants decreases the intensification of low density lipoprotein in vivo peroxidation during therapy with statins.
Lankin VZ; Tikhaze AK; Kukharchuk VV; Konovalova GG; Pisarenko OI; Kaminnyi AI; Shumaev KB; Belenkov YN
Mol Cell Biochem; 2003 Jul; 249(1-2):129-40. PubMed ID: 12956408
[TBL] [Abstract][Full Text] [Related]
18. Naturally occurring modified low density lipoproteins are similar if not identical: more electronegative and desialylated lipoprotein subfractions.
Tertov VV; Bittolo-Bon G; Sobenin IA; Cazzolato G; Orekhov AN; Avogaro P
Exp Mol Pathol; 1995 Jun; 62(3):166-72. PubMed ID: 8612720
[TBL] [Abstract][Full Text] [Related]
19. Changes in low-density lipoprotein electronegativity and oxidizability after aerobic exercise are related to the increase in associated non-esterified fatty acids.
Benítez S; Sánchez-Quesada JL; Lucero L; Arcelus R; Ribas V; Jorba O; Castellví A; Alonso E; Blanco-Vaca F; Ordóñez-Llanos J
Atherosclerosis; 2002 Jan; 160(1):223-32. PubMed ID: 11755941
[TBL] [Abstract][Full Text] [Related]
20. Oxidation of apolipoprotein B-100 in circulating LDL is related to LDL residence time. In vivo insights from stable-isotope studies.
Pietzsch J; Lattke P; Julius U
Arterioscler Thromb Vasc Biol; 2000 Oct; 20(10):E63-7. PubMed ID: 11031225
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
